학술논문
PO.6.135 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and phase II study design in patients with SLE and/or CLE (WILLOW)
Document Type
article
Author
Source
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Subject
Language
English
ISSN
2053-8790